Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific TH1 and TH2 cell responses in Cry j 2-primed mice

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 6 II, 1998, Pages 961-967

  Hirahara, Kazuki ^a   Saito, Saburo ^b   Serizawa, Nobufusa ^a   Sasaki, Reiko ^c   Sakaguchi, Masahiro ^c   Inouye, Sakae ^c   Taniguchi, Yoshifumi ^d   Kaminogawa, Shuichi ^e   Shiraishi, Akio ^a  

^a DAIICHI SANKYO CO   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

IgE; Japanese cedar pollen; Oral immunotherapy; Oral tolerance; Peptide; Pollinosis; T cell epitope; TH1 TH2

Indexed keywords

ALLERGEN; CHOLERA TOXIN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 2; INTERLEUKIN 4; SYNTHETIC PEPTIDE;

ALLERGY; ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PASSIVE SKIN ANAPHYLAXIS; POLLEN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0032416930     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(98)70334-3     Document Type: Article

References (36)

1. Yasueda H, Yui Y, Shimizu T, Shida T. Isolation and partial characterization of the major allergen from Japanese cedar (Cryptomeria japonica) pollen. J Allergy Clin Immunol 1983;71:77-86.
2. Sone T, Komiyama N, Shimizu K, Kusakabe T, Morikubo K, Kino K. Cloning and sequencing of cDNA coding for Cry j I, a major allergen of Japanese cedar pollen. Biochem Biophys Res Commun 1994;199:619-25.
3. Sakaguchi M, Inouye S, Taniai M, Ando S, Usui M, Matuhasi T. Identification of the second major allergen of Japanese cedar pollen. Allergy 1990;45:309-12.
4. Namba M, Kurose M, Torigoe K, Hino K, Taniguchi Y, Fukuda S, et al. Molecular cloning of the second major allergen, Cry j II, from Japanese cedar pollen. FEBS Lett 1994;353:124-8.
5. Komiyama N, Sone T, Shimizu K, Morikubo K, Kino K. cDNA cloning and expression of Cry j II, the second major allergen of Japanese cedar pollen. Biochem Biophys Res Commun 1994;201:1021-8.
6. Hashimoto M, Nigi H, Sakaguchi M, Inoue S, Imaoka K, Miyazawa H, et al. Sensitivity to two major allergens (Cryj I and Cryj II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis. Clin Exp Allergy 1995;25:848-52.
7. Sugimura K, Hashiguchi S, Takahashi Y, Hino K, Taniguchi Y, Kurimoto M, et al. Th1/Th2 response profiles to the major allergens Cry j 1 and Cry j 2 of Japanese cedar pollen. Allergy 1996;51:732-40.
8. Weiner HL, Friedman A, Miller A, Khoury SJ, Al-Sabbagh A, Santos L, et al. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Ann Rev Immunol 1994;12:809-37.
9. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997;18:335-43.
10. Chen Y, Inobe J, Marks R, Gonella P, Kuchroo VK, Weiner HL. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 1995;376:177-80.
11. Melamed D, Friedman A. In vivo tolerization of Th1 lymphocytes following a single feeding with ovalbumin: anergy in the absence of suppression. Eur J Immunol 1994;24:1974-81.
12. Houten NV, Blake SF. Direct measurement of anergy of antigen-specific T cells following oral tolerance induction. J Immunol 1996;157:1337-41.
13. Friedman A, Weiner HL. Induction of anergy or active suppression is determined by antigen dosage. Proc Natl Acad Sci USA 1994;91:6688-92.
14. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc Natl Acad Sci USA 1992;89:421-5.
15. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-40.
16. Suko M, Mori A, Ito K, Okudaira H. Oral immunotherapy may induce T cell anergy. Int Arch Allergy Immunol 1995;107:278-81.
17. Hetzel C, Hoyne GF, Lamb JR. Peptide-mediated immunoregulation. Int Arch Allergy Immunol 1995;107:275-7.
18. Wallner BP, Gefter ML. Peptide therapy for treatment of allergic diseases. Clin Immunol Immunopathol 1996;80:105-9.
19. Hirahara K, Hisatsune T, Choi C-Y, Kaminogawa S. Profound immunological tolerance in the antibody responses against bovine αs1-casein induced by intradermal administration of a dominant T cell determinant. Clin Immunol Immunopathol 1995;76:12-8.
20. Hoyne GF, O'Hehir RE, Wraith DC, Thomas WR, Lamb JR. Inhibition of T cell and antibody responses to house dust mite allergy by inhalation of the dominant T cell epitope in naive and sensitized mice. J Exp Med 1993;178:1783-8.
21. Briner TJ, Kou M-C, Keating KM, Rogers BL, Greenstein JL. Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc Natl Acad Sci USA 1993;90:7608-12.
22. Norman PS, Nicodemus CF, Creticos PS, Wood RA, Eggleston PA, Lichtenstein LM, et al. Clinical and immunologic effects of component peptides in Allervax® Cat. Int Arch Allergy Immunol 1997;113:224-6.
23. Nicodemus CF, Philip G, Jones N, Hirani S, Norman P. Integrated clinical experience with tolerogenic peptides. Int Arch Allergy Immunol 1997;113:326-8.
24. Tamura S, Yamanaka A, Shimohara M, Tomita T, Komase K, Tsuda Y, et al. Synergistic action of cholera toxin B subunit (and Escherichia coli-heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine. Vaccine 1994;12:419-26.
25. Marinaro M, Staats HF, Hiroi T, Jackson RJ, Coste M, Boyaka PC, et al. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol 1995;155:4621-9.
26. Kawashima T, Taniai M, Taniguchi Y, Usui M, Ando S, Kurimoto M, et al. Antigenic analyses of Sugi basic protein by monoclonal antibodies: I. distribution and characterization of B-cell-tropic epitopes of Cry j 1 molecule. Int Arch Allergy Immunol 1992;98:110-7.
27. Kawashima T, Taniai M, Usui M, Ando S, Kurimoto M, Matuhasi T. Antigenic analyses of Sugi basic protein by monoclonal antibodies: II. detection of immunoreactive fragments in enzyme-cleaved Cry j 1. Int Arch Allergy Immunol 1992;98:118-26.
28. Sakaguchi M, Inouye S, Miyazawa H, Tamura S. Measurement of antigen-specific mouse IgE by a fluorometric reverse (IgE-capture) ELISA. J Immunol Methods 1989;116:181-7.
29. Melamed D, F-Lobell J, Uni Z, Weiner HL, Friedman A. Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin. Int Immunol 1996;8:717-24.
30. Garside P, Steel M, Worthey FA, Satoskar A, Alexander J, Bluethmann H, et al. T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J Immunol 1995;154:5649-55.
31. + cells suppress experimental autoimmune uveitis. Eur J Immunol 1996;26:2140-8
32. Harrison LC, D-Collier M, Kramer DR, Takahashi K. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J Exp Med 1996;184:2167-74.
33. Ke Y, Pearce K, Lake JP, Ziegler HK, Kapp JA. γδ T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol 1997;158:3610-8.
34. McMenamin C, Pimm C, McKersey M, Holt PG. Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 1994;265:1869-71.
35. Ishikawa T, Ikagawa S, Masuyama K, Matsushita S, Nishimura Y Human T cell response to antigen peptides of Japanese cedar pollen (Cry j 1). Int Arch Allergy Immunol 1997;113:255-7.
36. Hashiguchi S, Hino K, Taniguchi Y, Kurimoto M, Fukuda K, Ohyama M, et al. Immunodominance of seven regions of a major allergen, Cry j 2, of Japanese cedar pollen for T cell immunity. Allergy 1996;51:621-32.